SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009730
Filing Date
2019-05-14
Accepted
2019-05-14 08:06:05
Documents
49
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20190331_10q.htm 10-Q 469279
2 EXHIBIT 10.1 ex_144620.htm EX-10.1 30447
3 EXHIBIT 10.2 ex_144621.htm EX-10.2 29480
4 EXHIBIT 10.3 ex_144366.htm EX-10.3 57783
5 EXHIBIT 31.1 ex_143016.htm EX-31.1 12380
6 EXHIBIT 31.2 ex_143017.htm EX-31.2 12378
7 EXHIBIT 32.1 ex_143018.htm EX-32.1 4618
8 EXHIBIT 32.2 ex_143019.htm EX-32.2 4958
  Complete submission text file 0001437749-19-009730.txt   2675520

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT snbp-20190331.xml EX-101.INS 419273
10 XBRL TAXONOMY EXTENSION SCHEMA snbp-20190331.xsd EX-101.SCH 31997
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20190331_cal.xml EX-101.CAL 25319
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20190331_def.xml EX-101.DEF 201963
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20190331_lab.xml EX-101.LAB 190140
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20190331_pre.xml EX-101.PRE 219812
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 19820506
SIC: 2834 Pharmaceutical Preparations